BIT biotron limited

0.00%

0.2¢

The enthusiasm last year was based on the pomise of imminent...

First 64 Last

Share
Profile

Follow
il duce

707 Posts.

145

17/11/24

19:01

Post #: 76646035
Share

Originally posted by Pseudoname1: ↑

It comes diown to the CR and (subject to timings) the CR depends on what we have not yet seen.

The point here is whilst the madding crowd may be correct in terms of an eventual outcome (may be) a lot of the discussion here regards marginal or circumstantial considerations that while they may provide a basis for a view, they are not empirical evidence.

That simply means that we don't definitively know, furthermore, that the reliance on such an approach is flawed and it's promotion is as concerning as the behaviours critiqued.

it's likely fair to say that the enthusiasm held this time last year was also not based on empirical evidence, but clearly the potential contemporaneous upside reward outweighs prevailing downside risk.

Given the impending liquidity crisis and the SP resilience, one must assume that either investors are indifferent, perceive merrit remains in the upside argument, or see a benefit for being a holder beyond an insolvency point.

You have to remember not everyone looks through the same lens. Some are as you say more 'equal' than others.

I think this should get interesting by the AGM.

An AGM scenario with no attempted CR or liquidity solution discussed and no announcemen re finals or a progress update would more likely lead me to more closely align to your thinking.... I can't see that transpiring, but we're it to I'd be thinking incompetence or much worse, malfeasance.

ie if historical testing is ignored and say dengue fefer is championed, raise sought I'd be beyond perplexed.

For now we wait results and response. If the narrative is reasonable I would not be surprised if CR is achieved. If CR is achieved, it will likely mean an identified niche fior the technology, and say (guessing) sponsorship of further testing. As indicated, it would appear a longer test window may better illustrate benefit. Ph 2c? / other ?

Absolute wild card might be an offer. As they say no news is good news.

I can understand why people without tolerance for downside risk would jump out prior to the AGM. It's not atypical of thiss situations.

Of course for every shsre sold at these levels, there has had to be va buyer. Given the perception of risk discussed here and the stability of the price t could actually be looked at aa a strong case for the bid surely.?

Either the iffer knows or expect they know something different than is voiced here, or posdibly holders are waiting for more empirical evidence to rely upon..

Expand

The enthusiasm last year was based on the pomise of imminent headline results and promises they were working fast and furiously.

Trust was destroyed. The rest is history.

The autopsy is already underway and it's not before time.

The track record of this BOD is appaling and some of them have form on other listed stocks. Another reason I believe BP aren't interested.

BIT Price at posting: 2.0¢ Sentiment: Sell Disclosure: Not Held
4 Upvote

1 Great analysis

Reply

Top Stories

BPH

Australia’s gas crisis is here – and dying coal plants aren’t helping

AII

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

MVF

Monash IVF shares cater 25% – Disaster or deep-value play?

SRL

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

RMX

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

PAR

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

OCC

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

First 64 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 0.2¢		Change 0.000(0.00%)		Mkt cap ! $2.654M

Open	High	Low	Value	Volume
0.2¢	0.2¢	0.2¢	$210	104.8K

Buyers (Bids)

No.	Vol.	Price($)
64	38848316	0.2¢

Sellers (Offers)

Price($)	Vol.	No.
0.3¢	18281126	25

View Market Depth

No.	Vol.	Price($)
59	37148316	0.002
33	65631001	0.001
0	0	0.000
0	0	0.000
0	0	0.000

Price($)	Vol.	No.
0.003	14162401	23
0.004	12820969	17
0.005	6684000	5
0.006	1200000	2
0.007	1084188	2

Last trade - 12.28pm 27/06/2025 (20 minute delay)

BIT (ASX) Chart

The enthusiasm last year was based on the pomise of imminent...

Australia’s gas crisis is here – and dying coal plants aren’t helping

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

Monash IVF shares cater 25% – Disaster or deep-value play?

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

The enthusiasm last year was based on the pomise of imminent...

Top Stories

Australia’s gas crisis is here – and dying coal plants aren’t helping

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

Monash IVF shares cater 25% – Disaster or deep-value play?

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News